HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gillette, Energizer Cross Razors Again With NAD Challenges

This article was originally published in The Rose Sheet

Executive Summary

Razor competitors Gillette and Energizer have each turned to the National Advertising Division to challenge claims made in the other's marketing, and both have been advised to modify advertising for their men's razors.

You may also be interested in...



P&G Supports Crest Sensi-Stop Strips Claims In More Than Name Only – NAD

P&G’s Crest Sensi-Stop Strips emerge largely unscathed from a NAD review of claims made in ads and on product packaging. While GSK argued some claims were unsupported, including the product name, NAD determined P&G’s evidence supports claims of immediate relief and protection for up to one month.

P&G Supports Crest Sensi-Stop Strips Claims In More Than Name Only – NAD

P&G’s Crest Sensi-Stop Strips emerge largely unscathed from a NAD review of claims made in ads and on product packaging. While GSK argued some claims were unsupported, including the product name, NAD determined P&G’s evidence supports claims of immediate relief and protection for up to one month.

GSK Overly Squeamish About Crest Sensi-Stop Strips Claims – NAD

P&G emerges largely unscathed from a National Advertising Division dispute regarding claims for Crest Sensi-Stop Strips, which challenger GlaxoSmithKline Consumer Healthcare argued were unsupported, including the product name. NAD determined the firm’s evidence adequate to support claims of immediate relief and protection for up to one month, among other statements made in ads and on product packaging.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017486

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel